Purpose
iSBTc is a society committed to investigating, developing and utilizing
biologicals and biological therapy for the treatment of malignant disease.
Mission
The mission of the International Society for Biological Therapy of Cancer
is to bring together those individuals actively involved in the preclinical
and clinical investigation of biological agents in the treatment of cancer
and to develop and promote educational programs, including an annual meeting,
which advance and promote the Society's purpose and mission.
Objectives
- Develop and promote training and credentialing programs in biological
treatment of cancer
- Collaborate with and support other scholarly societies and organizations
for the purpose of advancing and promoting iSBTc's purpose and mission
- Conduct clinical trials with biological agents in the treatment of
cancer and create and support consortia and alliances with other organizations
pursuing similar trials
- Engage in such other educational, training and informational activities
as will further or promote the Society's purpose and mission
Members: The Society for Biological Therapy was founded in
1984 with 40 charter members. Today its membership is comprised of over
400 national and international academics, clinicians, allied health
professionals, and government and industry representatives. At the business
meeting held November 9, 2002, the SBT membership voted to officially
change the name of the Society and it thus became the International
Society for Biological Therapy of Cancer (iSBTc).
EDI client since: 2001
|